These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 2270017)

  • 21. The low density lipoprotein receptor is not required for normal catabolism of Lp(a) in humans.
    Rader DJ; Mann WA; Cain W; Kraft HG; Usher D; Zech LA; Hoeg JM; Davignon J; Lupien P; Grossman M
    J Clin Invest; 1995 Mar; 95(3):1403-8. PubMed ID: 7883987
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Homozygous familial hypercholesterolemia.
    Diwan AG; Krishna KK; Jain MM; Arafat M; Sardesai VR; Dube MN
    J Assoc Physicians India; 2002 May; 50(5):738-9. PubMed ID: 12186142
    [No Abstract]   [Full Text] [Related]  

  • 23. Moderate phenotypic expression of familial hypercholesterolemia in Tunisia.
    Jelassi A; Slimani A; Jguirim I; Najah M; Abid A; Boughamoura L; Mzid J; Fkih M; Maatouk F; Rouis M; Varret M; Slimane MN
    Clin Chim Acta; 2010 May; 411(9-10):735-8. PubMed ID: 20144596
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Genetics of familial hypercholesterolemia].
    Sánchez Cascos A
    Rev Clin Esp; 1986 Feb; 178(2):44-5. PubMed ID: 3715103
    [No Abstract]   [Full Text] [Related]  

  • 25. Long-term effects of LDL apheresis in patients with severe hypercholesterolemia.
    Sachais BS; Katz J; Ross J; Rader DJ
    J Clin Apher; 2005 Dec; 20(4):252-5. PubMed ID: 15880364
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Kinetic value of LDL in familial hypercholesterolemia].
    Sáenz Aranzubia P; Piñan Lopez E
    An Esp Pediatr; 1991 Mar; 34(3):252-3. PubMed ID: 2064159
    [No Abstract]   [Full Text] [Related]  

  • 27. Lipoprotein metabolism in familial hypercholesterolemia.
    Shepherd J; Packard CJ
    Arteriosclerosis; 1989; 9(1 Suppl):I39-42. PubMed ID: 2912431
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of simvastatin on LDL-subtypes in patients with heterozygous familial hypercholesterolemia and in patients with diabetes mellitus and mixed hyperlipoproteinemia.
    Geiss HC; Schwandt P; Parhofer KG
    Exp Clin Endocrinol Diabetes; 2002 Jun; 110(4):182-7. PubMed ID: 12058342
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Clinical significance of current perspectives in cholesterol metabolism].
    Stalenhoef AF; van 't Laar A
    Ned Tijdschr Geneeskd; 1986 May; 130(21):951-5. PubMed ID: 3724871
    [No Abstract]   [Full Text] [Related]  

  • 30. [LDL receptors].
    Ducobu J
    Rev Med Brux; 1990 Dec; 11(10):481-92. PubMed ID: 2293288
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Physiopathology of primary hyperlipidemias].
    Luc G; Turpin G; De Gennes JL
    Ann Med Interne (Paris); 1986; 137(2):155-66. PubMed ID: 3521430
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low-density lipoprotein (LDL) receptors and the regulation of serum LDL levels.
    Vermeer BJ
    Neth J Med; 1985; 28(2):52-8. PubMed ID: 3919323
    [No Abstract]   [Full Text] [Related]  

  • 33. Characterization of a novel cellular defect in patients with phenotypic homozygous familial hypercholesterolemia.
    Norman D; Sun XM; Bourbon M; Knight BL; Naoumova RP; Soutar AK
    J Clin Invest; 1999 Sep; 104(5):619-28. PubMed ID: 10487776
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Disorders of lipoprotein and cholesterol metabolism in familial hypercholesterolemia].
    Wehr H
    Pol Arch Med Wewn; 1982; 67(1-2):47-52. PubMed ID: 7050936
    [No Abstract]   [Full Text] [Related]  

  • 35. The Lebanese allele at the LDLR in normocholesterolemic people merits reconsideration of genotype phenotype correlations in familial hypercholesterolemia.
    Fahed AC; Bitar FF; Khalaf RI; Moubarak EM; Azar ST; Nemer GM
    Endocrine; 2012 Oct; 42(2):445-8. PubMed ID: 22487947
    [No Abstract]   [Full Text] [Related]  

  • 36. [Genetic aspects of dyslipoproteinemias].
    de Gennes JL
    Bull Acad Natl Med; 1985 Jun; 169(6):729-34. PubMed ID: 3002561
    [No Abstract]   [Full Text] [Related]  

  • 37. The pathogenesis of hyperlipoproteinaemia.
    Shepherd J; Packard CJ
    Scott Med J; 1986 Jul; 31(3):154-61. PubMed ID: 3798078
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relationship between LDL receptor activity and development of coronary heart disease in Japanese cases with heterozygous familial hypercholesterolemia.
    Yamashita S; Kawamoto T; Ueyama Y; Funahashi T; Hara H; Hirobe K; Matsuzawa Y; Yamamoto A; Tarui S
    Artery; 1987; 15(1):24-43. PubMed ID: 3435251
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The LDL receptor defect in familial hypercholesterolemia. Implications for pathogenesis and therapy.
    Goldstein JL; Brown MS
    Med Clin North Am; 1982 Mar; 66(2):335-62. PubMed ID: 6279983
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Familial hypercholesterolemia--a receptor disease].
    Sobra J; Ceska R
    Cas Lek Cesk; 1988 Aug; 127(33):1033-6. PubMed ID: 3180167
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.